Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019
Deaths involving synthetic opioids other than methadone (synthetic opioids), which largely consist of illicitly manufactured fentanyl; psychostimulants with abuse potential (e.g., methamphetamine); and cocaine have increased in recent years, particularly since 2013 (1,2). In 2019, a total of 70,630...
Gespeichert in:
Veröffentlicht in: | MMWR. Morbidity and mortality weekly report 2021-02, Vol.70 (6), p.202-207 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 207 |
---|---|
container_issue | 6 |
container_start_page | 202 |
container_title | MMWR. Morbidity and mortality weekly report |
container_volume | 70 |
creator | Mattson, Christine L Tanz, Lauren J Quinn, Kelly Kariisa, Mbabazi Patel, Priyam Davis, Nicole L |
description | Deaths involving synthetic opioids other than methadone (synthetic opioids), which largely consist of illicitly manufactured fentanyl; psychostimulants with abuse potential (e.g., methamphetamine); and cocaine have increased in recent years, particularly since 2013 (1,2). In 2019, a total of 70,630 drug overdose deaths occurred, corresponding to an age-adjusted rate of 21.6 per 100,000 population and a 4.3% increase from the 2018 rate (20.7) (3). CDC analyzed trends in age-adjusted overdose death rates involving synthetic opioids, psychostimulants, cocaine, heroin, and prescription opioids during 2013-2019, as well as geographic patterns in synthetic opioid- and psychostimulant-involved deaths during 2018-2019. From 2013 to 2019, the synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4 per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0 (16,167) in 2019. In the presence of synthetic opioid coinvolvement, death rates for prescription opioids, heroin, psychostimulants, and cocaine increased. In the absence of synthetic opioid coinvolvement, death rates increased only for psychostimulants and cocaine. From 2018 to 2019, the largest relative increase in the synthetic opioid-involved death rate occurred in the West (67.9%), and the largest relative increase in the psychostimulant-involved death rate occurred in the Northeast (43.8%); these increases represent important changes in the geographic distribution of drug overdose deaths. Evidence-based prevention and response strategies including substance use disorder treatment and overdose prevention and response efforts focused on polysubstance use must be adapted to address the evolving drug overdose epidemic. |
doi_str_mv | 10.15585/mmwr.mm7006a4 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7877587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A652181682</galeid><sourcerecordid>A652181682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c695t-b9e4a8de93a73862eacfb4762d55e89456a050bef59195209e8530bdd7bc6733</originalsourceid><addsrcrecordid>eNp1kl2L1DAUhoso7uzqrZdSFLyyY9I0XzfCsqursDCCI3gX0va0jbRJTdLV_feb2S8cGBNIIOc570lO3ix7hdEaUyroh2n649fTxBFiunqSrTCtaCEY_vk0WyFcyaLEkh5lxyH8QrtB0PPsiBDKMRZolXVbD7YNubZtfgGu93oeTJN_0zGCtyE3Nj_3S38b_35t4wAxhTezcabNN1fgWxcgPwcdh5AX-Q9rIiQy6gjhfV4iTIq0yBfZs06PAV7e7yfZ9vOn7dmX4nJz8fXs9LJomKSxqCVUWrQgieZEsBJ009UVZ2VLKQhZUaYRRTV0VKZXlUiCoATVbcvrhnFCTrKPd7LzUk_QNmCj16OavZm0v1ZOG7UfsWZQvbtSXHBOBU8Cb-4FvPu9QIjKw-x8DKrklErEJNpVeXsH9XoEZWznklYzmdCoU0ZLLDATZaKKA1QPFlJhZ6Ez6XiPXx_g02xhMs3BhHd7CYmJ8Df2eglB_R8cQI_ps9y4RONsOHiFxrsQPHSPncNI3dpN7eymHuyWEl7_2-9H_MFf5AbN_c2o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2755906903</pqid></control><display><type>article</type><title>Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Mattson, Christine L ; Tanz, Lauren J ; Quinn, Kelly ; Kariisa, Mbabazi ; Patel, Priyam ; Davis, Nicole L</creator><creatorcontrib>Mattson, Christine L ; Tanz, Lauren J ; Quinn, Kelly ; Kariisa, Mbabazi ; Patel, Priyam ; Davis, Nicole L</creatorcontrib><description>Deaths involving synthetic opioids other than methadone (synthetic opioids), which largely consist of illicitly manufactured fentanyl; psychostimulants with abuse potential (e.g., methamphetamine); and cocaine have increased in recent years, particularly since 2013 (1,2). In 2019, a total of 70,630 drug overdose deaths occurred, corresponding to an age-adjusted rate of 21.6 per 100,000 population and a 4.3% increase from the 2018 rate (20.7) (3). CDC analyzed trends in age-adjusted overdose death rates involving synthetic opioids, psychostimulants, cocaine, heroin, and prescription opioids during 2013-2019, as well as geographic patterns in synthetic opioid- and psychostimulant-involved deaths during 2018-2019. From 2013 to 2019, the synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4 per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0 (16,167) in 2019. In the presence of synthetic opioid coinvolvement, death rates for prescription opioids, heroin, psychostimulants, and cocaine increased. In the absence of synthetic opioid coinvolvement, death rates increased only for psychostimulants and cocaine. From 2018 to 2019, the largest relative increase in the synthetic opioid-involved death rate occurred in the West (67.9%), and the largest relative increase in the psychostimulant-involved death rate occurred in the Northeast (43.8%); these increases represent important changes in the geographic distribution of drug overdose deaths. Evidence-based prevention and response strategies including substance use disorder treatment and overdose prevention and response efforts focused on polysubstance use must be adapted to address the evolving drug overdose epidemic.</description><identifier>ISSN: 0149-2195</identifier><identifier>EISSN: 1545-861X</identifier><identifier>DOI: 10.15585/mmwr.mm7006a4</identifier><identifier>PMID: 33571180</identifier><language>eng</language><publisher>United States: U.S. Government Printing Office</publisher><subject>Analgesics, Opioid - poisoning ; Analysis ; Cocaine ; Drug overdose ; Drug Overdose - mortality ; Drugs ; Enforcement ; Full Report ; Geography ; Humans ; Methadone ; Morbidity ; Mortality ; Mortality - trends ; Narcotics ; Opioids ; Overdose ; Synthetic Drugs - poisoning ; United States - epidemiology ; Vital statistics ; West Virginia</subject><ispartof>MMWR. Morbidity and mortality weekly report, 2021-02, Vol.70 (6), p.202-207</ispartof><rights>COPYRIGHT 2021 U.S. Government Printing Office</rights><rights>COPYRIGHT 2021 U.S. Government Printing Office</rights><rights>Published 2021. This article is a U.S. Government work and is in the public domain in the USA.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c695t-b9e4a8de93a73862eacfb4762d55e89456a050bef59195209e8530bdd7bc6733</citedby><cites>FETCH-LOGICAL-c695t-b9e4a8de93a73862eacfb4762d55e89456a050bef59195209e8530bdd7bc6733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877587/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877587/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33571180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mattson, Christine L</creatorcontrib><creatorcontrib>Tanz, Lauren J</creatorcontrib><creatorcontrib>Quinn, Kelly</creatorcontrib><creatorcontrib>Kariisa, Mbabazi</creatorcontrib><creatorcontrib>Patel, Priyam</creatorcontrib><creatorcontrib>Davis, Nicole L</creatorcontrib><title>Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019</title><title>MMWR. Morbidity and mortality weekly report</title><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><description>Deaths involving synthetic opioids other than methadone (synthetic opioids), which largely consist of illicitly manufactured fentanyl; psychostimulants with abuse potential (e.g., methamphetamine); and cocaine have increased in recent years, particularly since 2013 (1,2). In 2019, a total of 70,630 drug overdose deaths occurred, corresponding to an age-adjusted rate of 21.6 per 100,000 population and a 4.3% increase from the 2018 rate (20.7) (3). CDC analyzed trends in age-adjusted overdose death rates involving synthetic opioids, psychostimulants, cocaine, heroin, and prescription opioids during 2013-2019, as well as geographic patterns in synthetic opioid- and psychostimulant-involved deaths during 2018-2019. From 2013 to 2019, the synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4 per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0 (16,167) in 2019. In the presence of synthetic opioid coinvolvement, death rates for prescription opioids, heroin, psychostimulants, and cocaine increased. In the absence of synthetic opioid coinvolvement, death rates increased only for psychostimulants and cocaine. From 2018 to 2019, the largest relative increase in the synthetic opioid-involved death rate occurred in the West (67.9%), and the largest relative increase in the psychostimulant-involved death rate occurred in the Northeast (43.8%); these increases represent important changes in the geographic distribution of drug overdose deaths. Evidence-based prevention and response strategies including substance use disorder treatment and overdose prevention and response efforts focused on polysubstance use must be adapted to address the evolving drug overdose epidemic.</description><subject>Analgesics, Opioid - poisoning</subject><subject>Analysis</subject><subject>Cocaine</subject><subject>Drug overdose</subject><subject>Drug Overdose - mortality</subject><subject>Drugs</subject><subject>Enforcement</subject><subject>Full Report</subject><subject>Geography</subject><subject>Humans</subject><subject>Methadone</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Mortality - trends</subject><subject>Narcotics</subject><subject>Opioids</subject><subject>Overdose</subject><subject>Synthetic Drugs - poisoning</subject><subject>United States - epidemiology</subject><subject>Vital statistics</subject><subject>West Virginia</subject><issn>0149-2195</issn><issn>1545-861X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kl2L1DAUhoso7uzqrZdSFLyyY9I0XzfCsqursDCCI3gX0va0jbRJTdLV_feb2S8cGBNIIOc570lO3ix7hdEaUyroh2n649fTxBFiunqSrTCtaCEY_vk0WyFcyaLEkh5lxyH8QrtB0PPsiBDKMRZolXVbD7YNubZtfgGu93oeTJN_0zGCtyE3Nj_3S38b_35t4wAxhTezcabNN1fgWxcgPwcdh5AX-Q9rIiQy6gjhfV4iTIq0yBfZs06PAV7e7yfZ9vOn7dmX4nJz8fXs9LJomKSxqCVUWrQgieZEsBJ009UVZ2VLKQhZUaYRRTV0VKZXlUiCoATVbcvrhnFCTrKPd7LzUk_QNmCj16OavZm0v1ZOG7UfsWZQvbtSXHBOBU8Cb-4FvPu9QIjKw-x8DKrklErEJNpVeXsH9XoEZWznklYzmdCoU0ZLLDATZaKKA1QPFlJhZ6Ez6XiPXx_g02xhMs3BhHd7CYmJ8Df2eglB_R8cQI_ps9y4RONsOHiFxrsQPHSPncNI3dpN7eymHuyWEl7_2-9H_MFf5AbN_c2o</recordid><startdate>20210212</startdate><enddate>20210212</enddate><creator>Mattson, Christine L</creator><creator>Tanz, Lauren J</creator><creator>Quinn, Kelly</creator><creator>Kariisa, Mbabazi</creator><creator>Patel, Priyam</creator><creator>Davis, Nicole L</creator><general>U.S. Government Printing Office</general><general>U.S. Center for Disease Control</general><general>Centers for Disease Control and Prevention</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>88F</scope><scope>88J</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M1Q</scope><scope>M2O</scope><scope>M2R</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>S0X</scope><scope>5PM</scope></search><sort><creationdate>20210212</creationdate><title>Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019</title><author>Mattson, Christine L ; Tanz, Lauren J ; Quinn, Kelly ; Kariisa, Mbabazi ; Patel, Priyam ; Davis, Nicole L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c695t-b9e4a8de93a73862eacfb4762d55e89456a050bef59195209e8530bdd7bc6733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analgesics, Opioid - poisoning</topic><topic>Analysis</topic><topic>Cocaine</topic><topic>Drug overdose</topic><topic>Drug Overdose - mortality</topic><topic>Drugs</topic><topic>Enforcement</topic><topic>Full Report</topic><topic>Geography</topic><topic>Humans</topic><topic>Methadone</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Mortality - trends</topic><topic>Narcotics</topic><topic>Opioids</topic><topic>Overdose</topic><topic>Synthetic Drugs - poisoning</topic><topic>United States - epidemiology</topic><topic>Vital statistics</topic><topic>West Virginia</topic><toplevel>online_resources</toplevel><creatorcontrib>Mattson, Christine L</creatorcontrib><creatorcontrib>Tanz, Lauren J</creatorcontrib><creatorcontrib>Quinn, Kelly</creatorcontrib><creatorcontrib>Kariisa, Mbabazi</creatorcontrib><creatorcontrib>Patel, Priyam</creatorcontrib><creatorcontrib>Davis, Nicole L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Military Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Military Database</collection><collection>Research Library</collection><collection>Social Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>MMWR. Morbidity and mortality weekly report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mattson, Christine L</au><au>Tanz, Lauren J</au><au>Quinn, Kelly</au><au>Kariisa, Mbabazi</au><au>Patel, Priyam</au><au>Davis, Nicole L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019</atitle><jtitle>MMWR. Morbidity and mortality weekly report</jtitle><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><date>2021-02-12</date><risdate>2021</risdate><volume>70</volume><issue>6</issue><spage>202</spage><epage>207</epage><pages>202-207</pages><issn>0149-2195</issn><eissn>1545-861X</eissn><abstract>Deaths involving synthetic opioids other than methadone (synthetic opioids), which largely consist of illicitly manufactured fentanyl; psychostimulants with abuse potential (e.g., methamphetamine); and cocaine have increased in recent years, particularly since 2013 (1,2). In 2019, a total of 70,630 drug overdose deaths occurred, corresponding to an age-adjusted rate of 21.6 per 100,000 population and a 4.3% increase from the 2018 rate (20.7) (3). CDC analyzed trends in age-adjusted overdose death rates involving synthetic opioids, psychostimulants, cocaine, heroin, and prescription opioids during 2013-2019, as well as geographic patterns in synthetic opioid- and psychostimulant-involved deaths during 2018-2019. From 2013 to 2019, the synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4 per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0 (16,167) in 2019. In the presence of synthetic opioid coinvolvement, death rates for prescription opioids, heroin, psychostimulants, and cocaine increased. In the absence of synthetic opioid coinvolvement, death rates increased only for psychostimulants and cocaine. From 2018 to 2019, the largest relative increase in the synthetic opioid-involved death rate occurred in the West (67.9%), and the largest relative increase in the psychostimulant-involved death rate occurred in the Northeast (43.8%); these increases represent important changes in the geographic distribution of drug overdose deaths. Evidence-based prevention and response strategies including substance use disorder treatment and overdose prevention and response efforts focused on polysubstance use must be adapted to address the evolving drug overdose epidemic.</abstract><cop>United States</cop><pub>U.S. Government Printing Office</pub><pmid>33571180</pmid><doi>10.15585/mmwr.mm7006a4</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-2195 |
ispartof | MMWR. Morbidity and mortality weekly report, 2021-02, Vol.70 (6), p.202-207 |
issn | 0149-2195 1545-861X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7877587 |
source | MEDLINE; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Analgesics, Opioid - poisoning Analysis Cocaine Drug overdose Drug Overdose - mortality Drugs Enforcement Full Report Geography Humans Methadone Morbidity Mortality Mortality - trends Narcotics Opioids Overdose Synthetic Drugs - poisoning United States - epidemiology Vital statistics West Virginia |
title | Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A48%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20and%20Geographic%20Patterns%20in%20Drug%20and%20Synthetic%20Opioid%20Overdose%20Deaths%20-%20United%20States,%202013-2019&rft.jtitle=MMWR.%20Morbidity%20and%20mortality%20weekly%20report&rft.au=Mattson,%20Christine%20L&rft.date=2021-02-12&rft.volume=70&rft.issue=6&rft.spage=202&rft.epage=207&rft.pages=202-207&rft.issn=0149-2195&rft.eissn=1545-861X&rft_id=info:doi/10.15585/mmwr.mm7006a4&rft_dat=%3Cgale_pubme%3EA652181682%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2755906903&rft_id=info:pmid/33571180&rft_galeid=A652181682&rfr_iscdi=true |